Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medicinal honey for BAHI skin breakdown prevention
NCT03929224Phase 4Completed
- Sponsor
- Henry Ford Health
- Start
- Oct 2018
- Primary completion
- Sep 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Revamil in skin infection (SSTI), sponsored by Henry Ford Health. Primary endpoint: Holgers Classification of Skin Reactions at 6 months. Started Oct 2018; status: completed.
02
Drugs
Revamil
03
Conditions
skin infection (SSTI)
Beyond the preview
Go deeper on NCT03929224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03929224.